Trademark Overview
On Monday, April 7, 2025, a trademark application was filed for SURMATRIX with the United States Patent and Trademark Office. The USPTO has given the SURMATRIX trademark a serial number of 99124349. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, September 10, 2025. This trademark is owned by Surgenex Holdings, LLC. The SURMATRIX trademark is filed in the Pharmaceutical Products category with the following description:
Amniotic liquid allograft; Liquid biological preparations derived from human amnion, amniotic fluid and umbilical cord for medical and therapeutic use; Processed human donor skin for the replacement of soft tissue; injectable flowable human amniotic membrane allograft; flowable allograft tissue matrix derived from donated human amniotic membrane; Bone graft putty derived from demineralized bone matrix (DBM); Implantable living tissue, namely, bone, demineralized bone matrix, and derivatives of demineralized bone powder; Bone grafting products, namely, bone implants comprised of living tissue; Bone regenerating products comprised of living tissue, namely, demineralized bone matrix and derivatives of demineralized bone powder; Human allograft bone and tissue; Human allograft tissue in the nature of demineralized bone matrix used for use in surgical procedures; Surgical implants for the bone comprising living tissue in the nature of demineralized bone matrix for use in surgical procedures...
